- Report
- December 2023
- 172 Pages
Global
From €4722EUR$4,950USD£4,022GBP
- Report
- November 2023
- 263 Pages
Global
From €4722EUR$4,950USD£4,022GBP
- Report
- May 2024
- 192 Pages
Global
From €3219EUR$3,374USD£2,741GBP
€3576EUR$3,749USD£3,046GBP
- Report
- February 2024
- 110 Pages
Global
From €4531EUR$4,750USD£3,859GBP
- Report
- May 2024
- 224 Pages
Global
From €4578EUR$4,799USD£3,899GBP
- Report
- August 2023
- 395 Pages
Global
From €4007EUR$4,200USD£3,412GBP
- Report
- June 2024
- 360 Pages
Global
From €5199EUR$5,450USD£4,428GBP
- Report
- May 2024
- 175 Pages
Global
From €3816EUR$4,000USD£3,250GBP
- Report
- February 2024
- 175 Pages
Global
From €4770EUR$5,000USD£4,062GBP
- Report
- February 2024
- 175 Pages
Global
From €4770EUR$5,000USD£4,062GBP
- Report
- January 2024
- 200 Pages
Global
From €4770EUR$5,000USD£4,062GBP
- Report
- January 2024
- 200 Pages
Global
From €3816EUR$4,000USD£3,250GBP
- Report
- January 2024
- 200 Pages
Global
From €3816EUR$4,000USD£3,250GBP
- Report
- December 2023
- 200 Pages
Global
From €4770EUR$5,000USD£4,062GBP
- Report
- May 2024
- 185 Pages
Global
From €4674EUR$4,900USD£3,981GBP
- Report
- November 2023
- 188 Pages
Global
From €4674EUR$4,900USD£3,981GBP
- Report
- October 2023
- 190 Pages
Global
From €4674EUR$4,900USD£3,981GBP
- Report
- February 2024
- 169 Pages
Global
From €4531EUR$4,750USD£3,859GBP
- Report
- October 2023
Global
From €3434EUR$3,600USD£2,925GBP
- Report
- October 2023
North America
From €1431EUR$1,500USD£1,219GBP
Continuous bioprocessing is a biotechnology-based approach to the production of biopharmaceuticals, such as vaccines, monoclonal antibodies, and recombinant proteins. It involves the use of continuous manufacturing techniques, such as continuous cell culture, continuous chromatography, and continuous purification, to produce biopharmaceuticals in a more efficient and cost-effective manner than traditional batch-based processes. This approach also allows for greater control over the production process, resulting in higher quality products.
Continuous bioprocessing has become increasingly popular in recent years, as it offers a number of advantages over traditional batch-based processes. These include improved process control, increased product yield, reduced production costs, and shorter production times.
Some companies in the continuous bioprocessing market include Merck KGaA, Novartis, Pfizer, Sanofi, and Lonza. Show Less Read more